📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Engineering CD4+ T Cells to Enhance Cancer Immunity. (2020)

First Author: Sillito F

Attributed to: Precision targeting of mTOR in conventional and MHC class I-restricted anti-tumour CD4+ T cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cells9071721

PubMed Identifier: 32708397

Publication URI: http://europepmc.org/abstract/MED/32708397

Type: Journal Article/Review

Volume: 9

Parent Publication: Cells

Issue: 7

ISSN: 2073-4409